The in vivo Longevity of Antihaemophilic Factor (Factor VIII)
- 1 April 1964
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 10 (2), 225-237
- https://doi.org/10.1111/j.1365-2141.1964.tb00697.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- THE SURVIVAL OF FACTOR VIII (ANTIHEMOPHILIC GLOBULIN) AND FACTOR IX (PLASMA THROMBOPLASTIN COMPONENT) IN NORMAL HUMANS*Journal of Clinical Investigation, 1963
- Further Experience with a Concentrate Containing Human Antihaemophilic FactorBritish Journal of Haematology, 1963
- Screening Tests for Disorders of Thromboplastin Formation**With the technical assistance of Miss Eleanor Fort and Mrs. Joanne Lavender.Pediatric Clinics of North America, 1962
- Treatment of Classic Hemophilia: The Use of Fibrinogen Rich in Factor VIII for Hemorrhage and for SurgeryNew England Journal of Medicine, 1961
- Physiological Basis for Transfusion Therapy in Hemorrhagic Disorders: A Critical ReviewTransfusion, 1961
- Preparation and Properties of Serum and Plasma Proteins, XXXVVox Sanguinis, 1960
- Observations on Plasma Banking and Transfusion Procedures for Haemophihc Patients using a Quantitative Assay for Antihaemophilic Globulin (AHG)*British Journal of Haematology, 1959
- Treatment of Hemophilia A with Human Antihemophilic GlobulinActa Medica Scandinavica, 1958
- ASSAY OF ANTIHÆMOPHILIC GLOBULIN IN TREATMENT OF HÆMOPHILIC PATIENTSThe Lancet, 1957
- A CONCENTRATE OF HUMAN ANTIHÆMOPHILIC FACTOR: ITS USE IN SIX CASES OF HÆMOPHILIAThe Lancet, 1957